From Lab Innovation to Life-Saving Therapies: Gene Editing Therapeutics Market Poised to Hit US$ 6.26 Billion by 2032, Expanding at a 147.20% CAGR Driven by Rap…

Rapid advancements in CRISPR and next-generation gene editing technologies, combined with a strong clinical pipeline ...
Becker's Hospital Review

CRISPR gene editing may increase cancer risk in humans, two studies suggest

Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...
Nanowerk

A nanoplatform turns mild heat into a gene-editing trigger that disarms tumor defenses

Bismuthene nanodiscs use mild heat to switch on gene editing that dismantles a tumor's heat defenses, creating a feedback loop that kills cancer cells more effectively.
Hosted on MSN

CRISPR and the Ethics of Human Germline Intervention

Genetic modifications in reproductive cells, such as eggs, sperm, or embryos, are commonly referred to as germline editing and are heritable. 1 CRISPR-Cas 9, which stands for clustered regularly ...
University of California, Davis

A Gene Editor That's a Better Fit for Plants

Gene editing has enormous potential to help feed the world’s growing population, but it’s currently difficult, time-consuming ...
Frontiers

Gene Editing in Cancer Gene Therapy

Gene editing refers to the precise alteration of an organism's DNA sequence at a specific locus. In cancer treatment, this technology is leveraged to modify the genetic makeup of cancer cells, either ...
MarketBeat on MSN

CRISPR Therapeutics gains after earnings as pipeline hope grows

CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings ...
Medindia

Can DNA Editing Cure CGD, a Rare Immune Disorder?

Using prime editing, NCF1 mutation is corrected in a 19-year-old with chronic granulomatous disease, an inherited immune disorder, marking a gene therapy milestone.